Similar articles

• Combination of low-dose nalbuphine and morphine in patient-controlled analgesia decreases incidence of opioid-related side effects.

  Yeh YC, Lin TF, Chang HC, Chan WS, Wang YP, Lin CJ, Sun WZ. Yeh YC, et al. J Formos Med Assoc. 2009 Jul;108(7):548-53. doi: 10.1016/S0929-6646(09)60372-7. J Formos Med Assoc. 2009. PMID: 19586828 Clinical Trial.
• Variation in opioid use during PCA in adolescents.

  Marsh DF, Sigston PE. Marsh DF, et al. Paediatr Anaesth. 1996;6(5):429-30. Paediatr Anaesth. 1996. PMID: 8880829 No abstract available.
• Morphine at "sub-analgesic" background infusion rate plus low-dose PCA bolus control pain better and is as safe as twice a bolus-only PCA regimen: a randomized, double blind study.

  White I, Ghinea R, Avital S, Chazan S, Dolkart O, Weinbroum AA. White I, et al. Pharmacol Res. 2012 Aug;66(2):185-91. doi: 10.1016/j.phrs.2012.03.016. Epub 2012 Apr 6. Pharmacol Res. 2012. PMID: 22504462 Clinical Trial.
• [Patient-controlled analgesia in the management of postoperative pain-intravenous PCA].

  Hashiguchi S. Hashiguchi S. Masui. 2008 Nov;57 Suppl:S250-5. Masui. 2008. PMID: 22462185 Review. Japanese. No abstract available.
• [Intravenous patient-controlled analgesia (IV-PCA) for relief of postoperative pain].

  Mizuno J, Morita S, Hanaue N, Hanaoka K, Yokoyama T. Mizuno J, et al. Masui. 2011 Aug;60(8):908-12. Masui. 2011. PMID: 21861414 Review. Japanese.